title: Lymphoscintigraphy with 123I-labelled epidermal growth factor.
abstract: We have used 123I-labelled epidermal growth factor (EGF) scans to study 14 patients with advanced cervical cancer. Abnormal lymph node imaging was seen most clearly 6-8 h after the injection and revealed abnormal uptake by pelvic lymph nodes in 11 patients. 4 of these 11 had abnormal computerised tomographic and ultrasound scans; in the other 7 conventional radiology did not confirm the presence of disease.
authors.affiliation: 1st Department of Obstetrics and Gynaecology, University of Vienna, Austria.
authors.forename: C
authors.initials: C
authors.lastname: Schatten
authors.forename: N
authors.initials: N
authors.lastname: Pateisky
authors.forename: N
authors.initials: N
authors.lastname: Vavra
authors.forename: P
authors.initials: P
authors.lastname: Ehrenbock
authors.forename: P
authors.initials: P
authors.lastname: Angelberger
authors.forename: G
authors.initials: G
authors.lastname: Sivolapenko
authors.forename: A
authors.initials: A
authors.lastname: Epenetos
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000000981:diagnostic imaging*; D004815:Epidermal Growth Factor; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging*; D010388:Pelvis; D014055:Tomography, Emission-Computed; D002583:Uterine Cervical Neoplasms / Q000000981:diagnostic imaging*
chemical_list: D007457:Iodine Radioisotopes; D004815:Epidermal Growth Factor